Homepage

Investing
in life.

Making
an impact.

Working
together.

Investing
in life.

Making
an impact.

Working
together.

Seroba is a leading European life sciences venture capital firm focused on value creation through backing winning innovations in biotech and medtech.

Complement Therapeutics GmbH (CTx), a preclinical stage biotechnology company developing novel therapeutics for complement-mediated diseases, today announced the appointment of Dr Muhammad Ali Memon as its Chief Medical Officer, effective 1st January 2025. Dr. Memon is a qualified ophthalmologist and joins CTx from AAVantgarde Bio, where he held the position of Vice President, Clinical Science and Safety. Prior to AAVantgarde, …

  • Therapeutics
Explore

Shorla Oncology, (“Shorla”), a U.S.-Ireland specialty pharmaceutical company, announced today that the FDA has approved IMKELDI (imatinib) oral solution, the first oral liquid form of imatinib to treat certain forms of leukemia and other cancers. Leveraging Shorla’s novel technology, IMKELDI is an advanced liquid formulation of imatinib designed to provide dosing accuracy. IMKELDI can help slow or prevent the growth …

  • Medtech
Explore

Quanta Dialysis Technologies, a leader in transforming kidney care through its award-winning Quanta™ Dialysis System, has successfully closed its oversubscribed Series E Preferred Stock financing round, raising more than $60 million of additional capital. Led by Novo Holdings, Glenview Capital and b2venture, with broad participation by existing shareholders, this latest funding round underscores strong investor confidence in Quanta’s market potential to revolutionize …

  • Medtech
Explore
Discover all news

Complementary skill sets with deep investment and operational industry experience. Seroba helps entrepreneurs create and build world class businesses around extraordinary science.

  • Venture partner

Jeanne Bolger
  • Accountant

Anita Dipalo
  • CFO
  • Partner

Andrew Duignan
  • Operations Manager

Ciara Green
  • Investment Analyst

Sophie Hughes
  • Investor relations
  • Partner

Maud Lazare
  • Partner

Jennifer McMahon
  • Partner

Bruno Montanari
  • Partner

Alan O’Connell
  • Partner

Daniel O’Mahony
  • Partner

Catello Somma

A Portfolio of
Outstanding Companies
Discover full portfolio
Subscribe to our Newsletter
* = required field